Pirfenidone,Analysis control,HPLC≥99%

(The order shall be subject to the English name)

Product No.：M90301 CAS.：53179-13-8 Molecular formula：C₁₂H₁₁NO MDL：MFCD00866047 Brand：Acmec

Guess you like

Fenoxaprop-p-ethyl,

CAS No：71283-80-2

Pyrazolo[1，5-a]pyridine-4-carboxylic acid, 96%

CAS No：55899-41-7

Otophylloside O, Analysis control,96.5%

CAS No：1326583-08-7

2-Furoyl-LIGRLO-amide, 99%

CAS No：729589-58-6

5-(2，6-Dimethylphenyl)indoline, 97%

CAS No：1176740-73-0

Oxytetracycline, USP, 930 u/mg

CAS No：79-57-2

6-Methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide potassium salt, 98%

CAS No：55589-62-3

TRIBUTYL(ETHYNYL)TIN, 95%

CAS No：994-89-8

Globosides (GL4, Gb4, globotetraosyl Ceramide), 98%

CAS No：11034-93-8

2-Oxa-8-azaspiro[4.5]decan-1-one hydrochloride, 97%

CAS No：1314965-08-6

3-Bromo-6-methoxypyridin-2-amine,

CAS No：511541-63-2

Ethyl (S)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate,

CAS No：106939-34-8

2，6-bis[4-(diphenylamino)phenyl]- 9，10-Anthracenedione, >99 % (HPLC)， Sublimed

CAS No：1640978-33-1

Non Denatured Protein Precast Gel,15%, BR

CAS No：

Anti-HSF2 Polyclonal Antibody, BR

CAS No：

2-Nitrobenzaldehyde, Analysis control,HPLC≥99%

CAS No：552-89-6

Anti-DHFR2 Polyclonal Antibody, BR

CAS No：

SCM-PEG-SCM,0.8K, BR

CAS No：

4-Chloro-3-((3-chloro-5-(trifluoromethyl)pyridin-2-yl)oxy)aniline, 95%

CAS No：87170-48-7

20-hydroxy-5(Z),8(Z),11(Z),14(Z),17(Z)-eicosapentaenoic acid, 95%

CAS No：116477-57-7

Name：

Pirfenidone

CAS No.：

53179-13-8

Molecular formula：

C₁₂H₁₁NO

Molecular weight：

185.22

Density：

1.137±0.06 g/cm3(Predicted)

MeltingPoint：

96-97°C

BoilingPoint：

329.1±15.0°C(Predicted)

FlashPoint：

152.7°C

Solubility：

DMSO:199.8 mM

Preservation conditions：

2-8°C

InChIKey：

ISWRGOKTTBVCFA-UHFFFAOYSA-N

InChI：

InChI=1S/C12H11NO/c1-10-7-8-12(14)13(9-10)11-5-3-2-4-6-11/h2-9H,1H3

Pubchem ID：

40632

Grade of hazardous chemicals：

GHS：

HazardStatement：

H302

WarningStatement：

P261-P305+P351+P338

DangerCode：

R22

For detailed properties of compounds, click“哌非尼酮”

1. Cabozantinib ameliorates lipopolysaccharide-induced lung inflammation and bleomycin--induced early pulmonary fibrosis in mice

author：Xiaohe Li, Ling Ma, Yuli Wei, Jinying Gu, Jingjing Liang, Shimeng Li, Yunyao Cui, Rui Liu, Hui Huang, Cheng Yang, Honggang Zhou Influence factor：5.6 Periodical：International immunopharmacology PMID:34741997

technical information

History browsing record